CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in combination with paclitaxel and carboplatin (AUC4) when compared with carboplatin (AUC6) and paclitaxel alone in patients with advanced ovarian...
Phase 2
Portland, Oregon, United States and 41 other locations
be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the saf...
Phase 1, Phase 2
Portland, Oregon, United States and 8 other locations
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Portland, Oregon, United States and 46 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Portland, Oregon, United States and 50 other locations
A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer...
Phase 2, Phase 3
Portland, Oregon, United States and 38 other locations
in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian...
Phase 3
Portland, Oregon, United States and 117 other locations
This is a randomized, open label, multicenter trial to evaluate the safety, dosing, efficacy and biological activity of intraperitoneal IMNN-001 plus...
Phase 1, Phase 2
Portland, Oregon, United States and 20 other locations
of Mirvetuximab Soravtansine in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with hig...
Phase 2
Portland, Oregon, United States and 77 other locations
Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...
Phase 3
Portland, Oregon, United States and 202 other locations
in participants with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer...
Phase 3
Portland, Oregon, United States and 213 other locations
Clinical trials
Research sites
Resources
Legal